| Sign In to gain access to subscriptions and/or personal tools. |
Occupational health and staff monitoring: A genetic toxicologist's viewpointCancer Research Laboratory, Private Bag 92019, Auckland, New Zealand This is a summary of some of the points raised in a round table discussion on occupational health and in two workshops on staff monitoring, held as part of ISOPP IV. It is not intended as a comprehensive review on these issues. It is, however, intended to focus discussion on some of the controversial areas from the perspective of a genetic toxicologist. Pharmacists who have points to add or disagree with, or who wish to discuss or debate these issues further might address such comments as "Letters to the editor" in this journal.
Key Words: Environmental monitoring; biomonitoring epidemiology anticancer drugs mutagenicity carcinogenicity birth defects.
Journal of Oncology Pharmacy Practice, Vol. 1, No. 3,
49-54 (1995) |
|||